$VPHM Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in VIROPHARMA INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in VIROPHARMA INC. Get notifications about new insider transactions in VIROPHARMA INC for free.
Page: < prev 1 2 3 4 5 6 7 8 ... 11 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 20 2013 | VPHM | VIROPHARMA INC | Fletcher Robert C. | V.P., Business Deve ... | Payment of Exercise | F | 49.74 | 1,701 | 84,608 | 12,843 | 14.5 K to 12.8 K (-11.70 %) |
Dec 20 2013 | VPHM | VIROPHARMA INC | Fletcher Robert C. | V.P., Business Deve ... | Buy | M | 9.96 | 3,750 | 37,350 | 14,544 | 10.8 K to 14.5 K (+34.74 %) |
Dec 20 2013 | VPHM | VIROPHARMA INC | Fletcher Robert C. | V.P., Business Deve ... | Payment of Exercise | F | 49.74 | 5,522 | 274,664 | 10,794 | 16.3 K to 10.8 K (-33.84 %) |
Dec 20 2013 | VPHM | VIROPHARMA INC | Fletcher Robert C. | V.P., Business Deve ... | Buy | M | 13.97 | 9,000 | 125,730 | 16,316 | 7.3 K to 16.3 K (+123.02 %) |
Dec 20 2013 | VPHM | VIROPHARMA INC | Fletcher Robert C. | V.P., Business Deve ... | Payment of Exercise | F | 49.74 | 4,780 | 237,757 | 7,316 | 12.1 K to 7.3 K (-39.52 %) |
Dec 20 2013 | VPHM | VIROPHARMA INC | Fletcher Robert C. | V.P., Business Deve ... | Buy | M | 15.24 | 7,620 | 116,129 | 12,096 | 4.5 K to 12.1 K (+170.24 %) |
Dec 20 2013 | VPHM | VIROPHARMA INC | Fletcher Robert C. | V.P., Business Deve ... | Payment of Exercise | F | 49.74 | 3,288 | 163,545 | 4,476 | 7.8 K to 4.5 K (-42.35 %) |
Dec 20 2013 | VPHM | VIROPHARMA INC | Fletcher Robert C. | V.P., Business Deve ... | Buy | M | 8.71 | 7,535 | 65,630 | 7,764 | 229 to 7.8 K (+3,290.39 %) |
Jun 12 2013 | VPHM | VIROPHARMA INC | Wolf John Peter III | VP, General Counsel | Option Exercise | A | 27.79 | 32,516 | 903,620 | 32,516 | |
Jun 12 2013 | VPHM | VIROPHARMA INC | SOLAND DANIEL B | VP, Chief Operating ... | Option Exercise | A | 27.79 | 43,355 | 1,204,835 | 43,355 | |
Jun 12 2013 | VPHM | VIROPHARMA INC | Rowland Charles A Jr | VP, Chief Financial ... | Option Exercise | A | 27.79 | 32,516 | 903,620 | 32,516 | |
Jun 12 2013 | VPHM | VIROPHARMA INC | Pietrusko Robert | VP, Regulatory & Qu ... | Option Exercise | A | 27.79 | 32,516 | 903,620 | 32,516 | |
Jun 12 2013 | VPHM | VIROPHARMA INC | MILANO VINCENT | President and CEO | Option Exercise | A | 27.79 | 61,420 | 1,706,862 | 61,420 | |
Jun 12 2013 | VPHM | VIROPHARMA INC | Kirby John J. | V.P., Chief Account ... | Option Exercise | A | 27.79 | 6,000 | 166,740 | 6,000 | |
Jun 12 2013 | VPHM | VIROPHARMA INC | Fletcher Robert C. | V.P., Business Deve ... | Option Exercise | A | 27.79 | 32,516 | 903,620 | 32,516 | |
Jun 12 2013 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Option Exercise | A | 27.79 | 32,516 | 903,620 | 32,516 | |
Jun 12 2013 | VPHM | VIROPHARMA INC | DOYLE THOMAS F | VP Strategic Initia ... | Option Exercise | A | 27.79 | 32,516 | 903,620 | 32,516 | |
Feb 25 2013 | VPHM | VIROPHARMA INC | McHugh Julie | Director | Option Exercise | A | 25.25 | 15,000 | 378,750 | 15,000 | |
Feb 25 2013 | VPHM | VIROPHARMA INC | McHugh Julie | Director | Option Exercise | A | 0.00 | 4,500 | 0 | 4,500 | |
Feb 25 2013 | VPHM | VIROPHARMA INC | McHugh Julie | Director | Grant | A | 0.00 | 4,500 | 0 | 6,583 | 2.1 K to 6.6 K (+216.03 %) |
Feb 25 2013 | VPHM | VIROPHARMA INC | PIEN HOWARD H | Director | Option Exercise | A | 25.25 | 15,000 | 378,750 | 15,000 | |
Feb 25 2013 | VPHM | VIROPHARMA INC | PIEN HOWARD H | Director | Option Exercise | A | 0.00 | 4,500 | 0 | 4,500 | |
Feb 25 2013 | VPHM | VIROPHARMA INC | PIEN HOWARD H | Director | Grant | A | 0.00 | 4,500 | 0 | 9,000 | 4.5 K to 9 K (+100.00 %) |
Feb 25 2013 | VPHM | VIROPHARMA INC | GLASER ROBERT | Director | Option Exercise | A | 25.25 | 15,000 | 378,750 | 15,000 | |
Feb 25 2013 | VPHM | VIROPHARMA INC | GLASER ROBERT | Director | Option Exercise | A | 0.00 | 4,500 | 0 | 4,500 | |
Feb 25 2013 | VPHM | VIROPHARMA INC | GLASER ROBERT | Director | Grant | A | 0.00 | 4,500 | 0 | 45,860 | 41.4 K to 45.9 K (+10.88 %) |
Feb 25 2013 | VPHM | VIROPHARMA INC | Leone John R | Director | Option Exercise | A | 25.25 | 15,000 | 378,750 | 15,000 | |
Feb 25 2013 | VPHM | VIROPHARMA INC | Leone John R | Director | Option Exercise | A | 0.00 | 4,500 | 0 | 4,500 | |
Feb 25 2013 | VPHM | VIROPHARMA INC | Leone John R | Director | Grant | A | 0.00 | 4,500 | 0 | 11,000 | 6.5 K to 11 K (+69.23 %) |
Feb 25 2013 | VPHM | VIROPHARMA INC | DOUGHERTY MICHAEL R | Director | Option Exercise | A | 25.25 | 15,000 | 378,750 | 15,000 | |
Feb 25 2013 | VPHM | VIROPHARMA INC | DOUGHERTY MICHAEL R | Director | Option Exercise | A | 0.00 | 4,500 | 0 | 4,500 | |
Feb 25 2013 | VPHM | VIROPHARMA INC | DOUGHERTY MICHAEL R | Director | Grant | A | 0.00 | 4,500 | 0 | 11,500 | 7 K to 11.5 K (+64.29 %) |
Feb 25 2013 | VPHM | VIROPHARMA INC | CLAYPOOL WILLIAM D MD | Director | Option Exercise | A | 25.25 | 15,000 | 378,750 | 15,000 | |
Feb 25 2013 | VPHM | VIROPHARMA INC | CLAYPOOL WILLIAM D MD | Director | Option Exercise | A | 0.00 | 4,500 | 0 | 4,500 | |
Feb 25 2013 | VPHM | VIROPHARMA INC | CLAYPOOL WILLIAM D MD | Director | Grant | A | 0.00 | 4,500 | 0 | 49,000 | 44.5 K to 49 K (+10.11 %) |
Feb 25 2013 | VPHM | VIROPHARMA INC | BROOKE PAUL A | Director | Option Exercise | A | 25.25 | 15,000 | 378,750 | 15,000 | |
Feb 25 2013 | VPHM | VIROPHARMA INC | BROOKE PAUL A | Director | Option Exercise | A | 0.00 | 4,500 | 0 | 4,500 | |
Feb 25 2013 | VPHM | VIROPHARMA INC | BROOKE PAUL A | Director | Grant | A | 0.00 | 4,500 | 0 | 119,000 | 114.5 K to 119 K (+3.93 %) |
Feb 08 2013 | VPHM | VIROPHARMA INC | BROOKE PAUL A | Director | Option Exercise | M | 1.77 | 10,000 | 17,700 | 0 | |
Feb 08 2013 | VPHM | VIROPHARMA INC | BROOKE PAUL A | Director | Buy | M | 1.77 | 10,000 | 17,700 | 114,500 | 104.5 K to 114.5 K (+9.57 %) |
Jan 07 2013 | VPHM | VIROPHARMA INC | Wolf John Peter III | VP, General Counsel | Option Exercise | A | 23.37 | 34,570 | 807,901 | 34,570 | |
Jan 07 2013 | VPHM | VIROPHARMA INC | Rowland Charles A Jr | VP, Chief Financial ... | Option Exercise | A | 23.37 | 34,570 | 807,901 | 34,570 | |
Jan 07 2013 | VPHM | VIROPHARMA INC | SOLAND DANIEL B | VP, Chief Operating ... | Option Exercise | A | 23.37 | 46,093 | 1,077,193 | 46,093 | |
Jan 07 2013 | VPHM | VIROPHARMA INC | MILANO VINCENT | President and CEO | Option Exercise | A | 23.37 | 65,299 | 1,526,038 | 65,299 | |
Jan 07 2013 | VPHM | VIROPHARMA INC | Pietrusko Robert | VP, Regulatory & Qu ... | Option Exercise | A | 23.37 | 34,570 | 807,901 | 34,570 | |
Jan 07 2013 | VPHM | VIROPHARMA INC | Fletcher Robert C. | V.P., Business Deve ... | Option Exercise | A | 23.37 | 34,570 | 807,901 | 34,570 | |
Jan 07 2013 | VPHM | VIROPHARMA INC | Kirby John J. | V.P., Chief Account ... | Option Exercise | A | 23.37 | 3,960 | 92,545 | 3,960 | |
Jan 07 2013 | VPHM | VIROPHARMA INC | DOYLE THOMAS F | VP Strategic Initia ... | Option Exercise | A | 23.37 | 34,570 | 807,901 | 34,570 | |
Jan 07 2013 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Option Exercise | A | 23.37 | 34,570 | 807,901 | 34,570 | |
Jan 03 2013 | VPHM | VIROPHARMA INC | McHugh Julie | Director | Grant | A | 0.00 | 2,083 | 0 | 2,083 | 0 to 2.1 K |
Dec 28 2012 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Option Exercise | M | 1.84 | 10,000 | 18,400 | 120,000 | |
Dec 28 2012 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Buy | M | 1.84 | 10,000 | 18,400 | 30,167 | 20.2 K to 30.2 K (+49.59 %) |
Dec 27 2012 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Option Exercise | M | 1.84 | 17,500 | 32,200 | 112,500 | |
Dec 27 2012 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Sell | S | 22.53 | 17,500 | 394,301 | 37,667 | 55.2 K to 37.7 K (-31.72 %) |
Dec 27 2012 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Buy | M | 1.84 | 17,500 | 32,200 | 55,167 | 37.7 K to 55.2 K (+46.46 %) |
Dec 17 2012 | VPHM | VIROPHARMA INC | BROOKE PAUL A | Director | Sell | S | 23.87 | 60,000 | 1,431,954 | 104,500 | 164.5 K to 104.5 K (-36.47 %) |
Dec 12 2012 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Option Exercise | M | 9.96 | 14,999 | 149,390 | 5,001 | |
Dec 12 2012 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Option Exercise | M | 8.86 | 50,000 | 443,000 | 50,000 | |
Dec 12 2012 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Option Exercise | M | 5.91 | 10,000 | 59,100 | 10,000 | |
Dec 12 2012 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Sell | S | 24.07 | 14,999 | 360,984 | 37,667 | 52.7 K to 37.7 K (-28.48 %) |
Dec 12 2012 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Buy | M | 9.96 | 14,999 | 149,390 | 52,666 | 37.7 K to 52.7 K (+39.82 %) |
Dec 12 2012 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Sell | S | 24.07 | 50,000 | 1,203,360 | 37,667 | 87.7 K to 37.7 K (-57.03 %) |
Dec 12 2012 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Buy | M | 8.86 | 50,000 | 443,000 | 87,667 | 37.7 K to 87.7 K (+132.74 %) |
Dec 12 2012 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Sell | S | 24.07 | 10,000 | 240,672 | 37,667 | 47.7 K to 37.7 K (-20.98 %) |
Dec 12 2012 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Buy | M | 5.91 | 10,000 | 59,100 | 47,667 | 37.7 K to 47.7 K (+26.55 %) |
Dec 05 2012 | VPHM | VIROPHARMA INC | Wolf John Peter III | VP, General Counsel | Option Exercise | M | 3.14 | 18,000 | 56,520 | 0 | |
Dec 05 2012 | VPHM | VIROPHARMA INC | Wolf John Peter III | VP, General Counsel | Sell | S | 24.85 | 18,000 | 447,257 | 0 | 18 K to 0 (-100.00 %) |
Dec 05 2012 | VPHM | VIROPHARMA INC | Wolf John Peter III | VP, General Counsel | Buy | M | 3.14 | 18,000 | 56,520 | 18,000 | 0 to 18 K |
Dec 05 2012 | VPHM | VIROPHARMA INC | DOUGHERTY MICHAEL R | Director | Buy | P | 25.07 | 2,500 | 62,675 | 7,000 | 4.5 K to 7 K (+55.56 %) |
Dec 05 2012 | VPHM | VIROPHARMA INC | CLAYPOOL WILLIAM D MD | Director | Sell | S | 24.80 | 10,000 | 248,000 | 44,500 | 54.5 K to 44.5 K (-18.35 %) |
Dec 04 2012 | VPHM | VIROPHARMA INC | GLASER ROBERT | Director | Option Exercise | M | 20.15 | 10,000 | 201,500 | 0 | |
Dec 04 2012 | VPHM | VIROPHARMA INC | GLASER ROBERT | Director | Option Exercise | M | 3.00 | 20,000 | 60,000 | 0 | |
Dec 04 2012 | VPHM | VIROPHARMA INC | GLASER ROBERT | Director | Sell | S | 24.78 | 10,000 | 247,795 | 41,360 | 51.4 K to 41.4 K (-19.47 %) |
Dec 04 2012 | VPHM | VIROPHARMA INC | GLASER ROBERT | Director | Buy | M | 20.15 | 10,000 | 201,500 | 51,360 | 41.4 K to 51.4 K (+24.18 %) |
Dec 04 2012 | VPHM | VIROPHARMA INC | GLASER ROBERT | Director | Sell | S | 24.78 | 20,000 | 495,590 | 41,360 | 61.4 K to 41.4 K (-32.59 %) |
Dec 04 2012 | VPHM | VIROPHARMA INC | GLASER ROBERT | Director | Buy | M | 3.00 | 20,000 | 60,000 | 61,360 | 41.4 K to 61.4 K (+48.36 %) |
Nov 30 2012 | VPHM | VIROPHARMA INC | CLAYPOOL WILLIAM D MD | Director | Option Exercise | M | 10.76 | 15,000 | 161,400 | 0 | |
Nov 30 2012 | VPHM | VIROPHARMA INC | CLAYPOOL WILLIAM D MD | Director | Option Exercise | M | 5.68 | 2,500 | 14,200 | 0 | |
Nov 30 2012 | VPHM | VIROPHARMA INC | CLAYPOOL WILLIAM D MD | Director | Sell | S | 24.22 | 15,000 | 363,326 | 54,500 | 69.5 K to 54.5 K (-21.58 %) |
Nov 30 2012 | VPHM | VIROPHARMA INC | CLAYPOOL WILLIAM D MD | Director | Buy | M | 10.76 | 15,000 | 161,400 | 69,500 | 54.5 K to 69.5 K (+27.52 %) |
Nov 30 2012 | VPHM | VIROPHARMA INC | CLAYPOOL WILLIAM D MD | Director | Sell | S | 24.22 | 2,500 | 60,554 | 54,500 | 57 K to 54.5 K (-4.39 %) |
Nov 30 2012 | VPHM | VIROPHARMA INC | CLAYPOOL WILLIAM D MD | Director | Buy | M | 5.68 | 2,500 | 14,200 | 57,000 | 54.5 K to 57 K (+4.59 %) |
Nov 30 2012 | VPHM | VIROPHARMA INC | MILANO VINCENT | President and CEO | Option Exercise | M | 3.55 | 18,000 | 63,900 | 40,309 | |
Nov 30 2012 | VPHM | VIROPHARMA INC | MILANO VINCENT | President and CEO | Buy | M | 3.55 | 18,000 | 63,900 | 112,416 | 94.4 K to 112.4 K (+19.06 %) |
Nov 15 2012 | VPHM | VIROPHARMA INC | CLAYPOOL WILLIAM D MD | Director | Option Exercise | M | 5.68 | 12,500 | 71,000 | 2,500 | |
Nov 15 2012 | VPHM | VIROPHARMA INC | CLAYPOOL WILLIAM D MD | Director | Option Exercise | M | 9.15 | 10,000 | 91,500 | 0 | |
Nov 15 2012 | VPHM | VIROPHARMA INC | CLAYPOOL WILLIAM D MD | Director | Sell | S | 25.01 | 12,500 | 312,585 | 54,500 | 67 K to 54.5 K (-18.66 %) |
Nov 15 2012 | VPHM | VIROPHARMA INC | CLAYPOOL WILLIAM D MD | Director | Buy | M | 5.68 | 12,500 | 71,000 | 67,000 | 54.5 K to 67 K (+22.94 %) |
Nov 15 2012 | VPHM | VIROPHARMA INC | CLAYPOOL WILLIAM D MD | Director | Sell | S | 24.84 | 10,000 | 248,426 | 54,500 | 64.5 K to 54.5 K (-15.50 %) |
Nov 15 2012 | VPHM | VIROPHARMA INC | CLAYPOOL WILLIAM D MD | Director | Buy | M | 9.15 | 10,000 | 91,500 | 64,500 | 54.5 K to 64.5 K (+18.35 %) |
Nov 13 2012 | VPHM | VIROPHARMA INC | MILANO VINCENT | President and CEO | Option Exercise | M | 3.14 | 41,418 | 130,053 | 18,582 | |
Nov 13 2012 | VPHM | VIROPHARMA INC | MILANO VINCENT | President and CEO | Option Exercise | M | 5.91 | 42,000 | 248,220 | 14,000 | |
Nov 13 2012 | VPHM | VIROPHARMA INC | MILANO VINCENT | President and CEO | Sell | S | 24.54 | 41,418 | 1,016,522 | 94,416 | 135.8 K to 94.4 K (-30.49 %) |
Nov 13 2012 | VPHM | VIROPHARMA INC | MILANO VINCENT | President and CEO | Buy | M | 3.14 | 41,418 | 130,053 | 135,834 | 94.4 K to 135.8 K (+43.87 %) |
Nov 13 2012 | VPHM | VIROPHARMA INC | MILANO VINCENT | President and CEO | Sell | S | 24.54 | 42,000 | 1,030,806 | 94,416 | 136.4 K to 94.4 K (-30.79 %) |
Nov 13 2012 | VPHM | VIROPHARMA INC | MILANO VINCENT | President and CEO | Buy | M | 5.91 | 42,000 | 248,220 | 136,416 | 94.4 K to 136.4 K (+44.48 %) |
Nov 05 2012 | VPHM | VIROPHARMA INC | CLAYPOOL WILLIAM D MD | Director | Sell | S | 25.37 | 10,000 | 253,703 | 54,500 | 64.5 K to 54.5 K (-15.50 %) |
Aug 22 2012 | VPHM | VIROPHARMA INC | Kirby John J. | V.P., Chief Account ... | Option Exercise | A | 26.93 | 15,000 | 403,950 | 15,000 | |
Jun 13 2012 | VPHM | VIROPHARMA INC | CLAYPOOL WILLIAM D MD | Director | Option Exercise | M | 3.42 | 10,000 | 34,200 | 0 | |
Jun 13 2012 | VPHM | VIROPHARMA INC | CLAYPOOL WILLIAM D MD | Director | Sell | S | 20.04 | 10,000 | 200,430 | 64,500 | 74.5 K to 64.5 K (-13.42 %) |
Jun 13 2012 | VPHM | VIROPHARMA INC | CLAYPOOL WILLIAM D MD | Director | Buy | M | 3.42 | 10,000 | 34,200 | 74,500 | 64.5 K to 74.5 K (+15.50 %) |
Jun 06 2012 | VPHM | VIROPHARMA INC | MILANO VINCENT | President and CEO | Option Exercise | A | 20.07 | 71,447 | 1,433,941 | 71,447 | |
Jun 06 2012 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Option Exercise | A | 20.07 | 35,723 | 716,961 | 35,723 | |
Jun 06 2012 | VPHM | VIROPHARMA INC | DOYLE THOMAS F | VP Strategic Initia ... | Option Exercise | A | 20.07 | 35,723 | 716,961 | 35,723 | |
Jun 06 2012 | VPHM | VIROPHARMA INC | Pietrusko Robert | VP, Regulatory & Qu ... | Option Exercise | A | 20.07 | 35,723 | 716,961 | 35,723 | |
Jun 06 2012 | VPHM | VIROPHARMA INC | Rowland Charles A Jr | VP, Chief Financial ... | Option Exercise | A | 20.07 | 35,723 | 716,961 | 35,723 | |
Jun 06 2012 | VPHM | VIROPHARMA INC | Morris Richard Steven | Chief Accounting Of ... | Option Exercise | A | 20.07 | 6,000 | 120,420 | 6,000 | |
Jun 06 2012 | VPHM | VIROPHARMA INC | SOLAND DANIEL B | VP, Chief Operating ... | Option Exercise | A | 20.07 | 48,334 | 970,063 | 48,334 | |
Jun 06 2012 | VPHM | VIROPHARMA INC | Fletcher Robert C. | V.P., Business Deve ... | Option Exercise | A | 20.07 | 35,723 | 716,961 | 35,723 | |
Jun 06 2012 | VPHM | VIROPHARMA INC | Wolf John Peter III | VP, General Counsel | Option Exercise | A | 20.07 | 35,723 | 716,961 | 35,723 | |
Mar 27 2012 | VPHM | VIROPHARMA INC | Pietrusko Robert | VP, Regulatory & Qu ... | Option Exercise | M | 8.86 | 20,000 | 177,200 | 60,000 | |
Mar 27 2012 | VPHM | VIROPHARMA INC | Pietrusko Robert | VP, Regulatory & Qu ... | Sell | S | 30.00 | 20,000 | 600,000 | 4,122 | 24.1 K to 4.1 K (-82.91 %) |
Mar 27 2012 | VPHM | VIROPHARMA INC | Pietrusko Robert | VP, Regulatory & Qu ... | Buy | M | 8.86 | 20,000 | 177,200 | 24,122 | 4.1 K to 24.1 K (+485.20 %) |
Mar 09 2012 | VPHM | VIROPHARMA INC | Rowland Charles A Jr | VP, Chief Financial ... | Option Exercise | M | 13.50 | 5,555 | 74,993 | 54,445 | |
Mar 09 2012 | VPHM | VIROPHARMA INC | Rowland Charles A Jr | VP, Chief Financial ... | Option Exercise | M | 11.96 | 25,083 | 299,993 | 39,917 | |
Mar 09 2012 | VPHM | VIROPHARMA INC | Rowland Charles A Jr | VP, Chief Financial ... | Payment of Exercise | F | 29.49 | 12,715 | 374,965 | 35,048 | 47.8 K to 35 K (-26.62 %) |
Mar 09 2012 | VPHM | VIROPHARMA INC | Rowland Charles A Jr | VP, Chief Financial ... | Buy | M | 13.50 | 5,555 | 74,993 | 47,763 | 42.2 K to 47.8 K (+13.16 %) |
Mar 09 2012 | VPHM | VIROPHARMA INC | Rowland Charles A Jr | VP, Chief Financial ... | Buy | M | 11.96 | 25,083 | 299,993 | 42,208 | 17.1 K to 42.2 K (+146.47 %) |
Mar 12 2012 | VPHM | VIROPHARMA INC | Morris Richard Steven | Chief Accounting Of ... | Option Exercise | M | 7.05 | 1,300 | 9,165 | 2,100 | |
Mar 12 2012 | VPHM | VIROPHARMA INC | Morris Richard Steven | Chief Accounting Of ... | Sell | S | 29.71 | 1,300 | 38,618 | 1,244 | 2.5 K to 1.2 K (-51.10 %) |
Mar 12 2012 | VPHM | VIROPHARMA INC | Morris Richard Steven | Chief Accounting Of ... | Buy | M | 7.05 | 1,300 | 9,165 | 2,544 | 1.2 K to 2.5 K (+104.50 %) |
Mar 13 2012 | VPHM | VIROPHARMA INC | SOLAND DANIEL B | VP, Chief Operating ... | Option Exercise | M | 12.83 | 31,176 | 399,988 | 68,824 | |
Mar 13 2012 | VPHM | VIROPHARMA INC | SOLAND DANIEL B | VP, Chief Operating ... | Option Exercise | M | 13.50 | 5,555 | 74,993 | 69,445 | |
Mar 13 2012 | VPHM | VIROPHARMA INC | SOLAND DANIEL B | VP, Chief Operating ... | Option Exercise | M | 9.96 | 5,001 | 49,810 | 14,999 | |
Mar 13 2012 | VPHM | VIROPHARMA INC | SOLAND DANIEL B | VP, Chief Operating ... | Option Exercise | M | 15.24 | 6,561 | 99,990 | 33,439 | |
Mar 13 2012 | VPHM | VIROPHARMA INC | SOLAND DANIEL B | VP, Chief Operating ... | Payment of Exercise | F | 29.65 | 21,071 | 624,755 | 70,103 | 91.2 K to 70.1 K (-23.11 %) |
Mar 13 2012 | VPHM | VIROPHARMA INC | SOLAND DANIEL B | VP, Chief Operating ... | Buy | M | 12.83 | 31,176 | 399,988 | 91,174 | 60 K to 91.2 K (+51.96 %) |
Mar 13 2012 | VPHM | VIROPHARMA INC | SOLAND DANIEL B | VP, Chief Operating ... | Buy | M | 13.50 | 5,555 | 74,993 | 59,998 | 54.4 K to 60 K (+10.20 %) |
Mar 13 2012 | VPHM | VIROPHARMA INC | SOLAND DANIEL B | VP, Chief Operating ... | Buy | M | 9.96 | 5,001 | 49,810 | 54,443 | 49.4 K to 54.4 K (+10.11 %) |
Mar 13 2012 | VPHM | VIROPHARMA INC | SOLAND DANIEL B | VP, Chief Operating ... | Buy | M | 15.24 | 6,561 | 99,990 | 49,442 | 42.9 K to 49.4 K (+15.30 %) |
Mar 12 2012 | VPHM | VIROPHARMA INC | Fletcher Robert C. | V.P., Business Deve ... | Option Exercise | M | 3.55 | 25,000 | 88,750 | 0 | |
Mar 12 2012 | VPHM | VIROPHARMA INC | Fletcher Robert C. | V.P., Business Deve ... | Option Exercise | M | 2.09 | 5,000 | 10,450 | 0 | |
Mar 12 2012 | VPHM | VIROPHARMA INC | Fletcher Robert C. | V.P., Business Deve ... | Option Exercise | M | 3.93 | 2,000 | 7,860 | 0 | |
Mar 12 2012 | VPHM | VIROPHARMA INC | Fletcher Robert C. | V.P., Business Deve ... | Sell | S | 29.65 | 32,000 | 948,954 | 229 | 32.2 K to 229 (-99.29 %) |
Mar 12 2012 | VPHM | VIROPHARMA INC | Fletcher Robert C. | V.P., Business Deve ... | Buy | M | 3.55 | 25,000 | 88,750 | 32,229 | 7.2 K to 32.2 K (+345.83 %) |
Mar 12 2012 | VPHM | VIROPHARMA INC | Fletcher Robert C. | V.P., Business Deve ... | Buy | M | 2.09 | 5,000 | 10,450 | 7,229 | 2.2 K to 7.2 K (+224.32 %) |
Mar 12 2012 | VPHM | VIROPHARMA INC | Fletcher Robert C. | V.P., Business Deve ... | Buy | M | 3.93 | 2,000 | 7,860 | 2,229 | 229 to 2.2 K (+873.36 %) |
Feb 28 2012 | VPHM | VIROPHARMA INC | BROOKE PAUL A | Director | Option Exercise | A | 0.00 | 4,500 | 0 | 4,500 | |
Feb 28 2012 | VPHM | VIROPHARMA INC | BROOKE PAUL A | Director | Option Exercise | A | 31.74 | 15,000 | 476,100 | 15,000 | |
Feb 28 2012 | VPHM | VIROPHARMA INC | BROOKE PAUL A | Director | Grant | A | 0.00 | 4,500 | 0 | 164,500 | 160 K to 164.5 K (+2.81 %) |
Mar 07 2012 | VPHM | VIROPHARMA INC | Morris Richard Steven | Chief Accounting Of ... | Option Exercise | M | 5.91 | 2,000 | 11,820 | 2,000 | |
Mar 07 2012 | VPHM | VIROPHARMA INC | Morris Richard Steven | Chief Accounting Of ... | Option Exercise | M | 7.05 | 3,300 | 23,265 | 3,400 | |
Mar 07 2012 | VPHM | VIROPHARMA INC | Morris Richard Steven | Chief Accounting Of ... | Sell | S | 33.01 | 5,300 | 174,953 | 1,244 | 6.5 K to 1.2 K (-80.99 %) |
Mar 07 2012 | VPHM | VIROPHARMA INC | Morris Richard Steven | Chief Accounting Of ... | Buy | M | 5.91 | 2,000 | 11,820 | 6,544 | 4.5 K to 6.5 K (+44.01 %) |
Mar 07 2012 | VPHM | VIROPHARMA INC | Morris Richard Steven | Chief Accounting Of ... | Buy | M | 7.05 | 3,300 | 23,265 | 4,544 | 1.2 K to 4.5 K (+265.27 %) |
Mar 07 2012 | VPHM | VIROPHARMA INC | DOYLE THOMAS F | VP Strategic Initia ... | Option Exercise | M | 3.14 | 60,000 | 188,400 | 0 | |
Mar 07 2012 | VPHM | VIROPHARMA INC | DOYLE THOMAS F | VP Strategic Initia ... | Option Exercise | M | 3.55 | 100,000 | 355,000 | 0 | |
Mar 07 2012 | VPHM | VIROPHARMA INC | DOYLE THOMAS F | VP Strategic Initia ... | Option Exercise | M | 2.09 | 30,000 | 62,700 | 0 | |
Mar 07 2012 | VPHM | VIROPHARMA INC | DOYLE THOMAS F | VP Strategic Initia ... | Option Exercise | M | 3.93 | 20,000 | 78,600 | 0 | |
Mar 07 2012 | VPHM | VIROPHARMA INC | DOYLE THOMAS F | VP Strategic Initia ... | Sell | S | 32.48 | 210,000 | 6,820,212 | 52,444 | 262.4 K to 52.4 K (-80.02 %) |